-
Hemispherx BioPharma CEO Talks Stock Performance, Financials And Partnerships
Wednesday, January 4, 2017 - 11:45am | 599Hemispherx BioPharma, Inc (NYSE: HEB) is a nano-cap biopharmaceutical research and development company that focuses on the treatment of seriously debilitating disorders. Its flagship products include Alferon N Injection, Ampligen and Alferon LDO. Benzinga recently had the chance to speak with the...
-
Hemispherx BioPharma CEO Talks About Ampligen, Alferon's Potential
Tuesday, January 3, 2017 - 4:10pm | 475Hemispherx BioPharma, Inc (NYSE: HEB) is a nano-cap biopharmaceutical research and development company that focuses on the treatment of seriously debilitating disorders. Its flagship products include Alferon N Injection, Ampligen and Alferon LDO. Benzinga recently had the chance to speak with the...